NAD+ is the coenzyme your cells use to turn food into usable energy. NMN (nicotinamide mononucleotide) is one of the building blocks your body makes NAD+ from.
So "NMN vs NAD+" is really a choice between taking a precursor and taking the finished molecule. The published human trials so far mostly test precursors like NMN, not oral NAD+ itself.
Infinite Labs offers both NMN and NAD+ capsules, giving you a choice between a precursor and the coenzyme itself. This guide explains the difference, compares the human research, and helps you choose a format that fits your routine.
What is the difference between NMN and NAD+?
- NAD+ is the active coenzyme. It shuttles electrons in the reactions that release energy from carbohydrates and fats, and it is used by enzymes involved in routine cellular maintenance.
- NMN sits one step before NAD+ in the pathway your body uses to make and recycle it.
- The evidence gap: several randomized human trials report higher blood NAD+ after oral NMN. Direct oral NAD+ research is newer and much more formulation-specific.
- How to choose: NMN has the broader published human trial base. Neither ingredient has established that raising a blood marker translates into a meaningful health or longevity benefit for a healthy shopper.
What is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is present in every cell you have. It works as a carrier: during metabolism it accepts electrons and becomes NADH, then hands them on and becomes NAD+ again.
That constant cycling is part of how your cells produce ATP, the energy currency they spend on everything from muscle contraction to repair work.
NAD+ is also consumed by enzymes such as sirtuins and PARPs, which are involved in cellular maintenance.
Because it is used up, your body keeps remaking it, mostly through a "salvage" pathway that recycles nicotinamide back into NAD+.
Age-related NAD+ changes are well studied in animals, but the human tissue evidence is uneven; a lower level in one tissue is not proof that a supplement reverses aging.
What is NMN?
NMN is a molecule your body makes from nicotinamide, a form of vitamin B3, and then converts into NAD+ in a single step.
The amounts used in supplement studies (250–900 mg a day) are far larger than anything a normal diet provides.
Other members of the same family include nicotinamide riboside (NR), nicotinamide and niacin. They all feed NAD+ production by different routes.
NMN vs NAD+ at a glance
| Question | NMN | NAD+ |
|---|---|---|
| What it is | A precursor your body turns into NAD+ | The active coenzyme itself |
| Where it fits | One step before NAD+ in the salvage pathway | The end product of that pathway |
| Human trials as an oral supplement | Several randomized, placebo-controlled trials, mostly small and short | A much smaller, formulation-specific evidence base, including a five-day trial of a proprietary oral NAD+ powder |
| What those trials mostly measure | Blood NAD+ levels, safety, and exploratory function tests | Short-term total NAD (NAD+ plus NADH) blood-cell biomarkers and tolerability for the specific formulation tested |
| Amounts used in cited studies | 250–900 mg daily in the trials discussed below | The proprietary trial scheduled 2 g powder (50% NAD+) in four divided doses daily, plus an extra night dose on days two and three—not comparable with a standard once-daily capsule |
| Infinite Labs formula | NMN: 500 mg per capsule, 60 capsules | NAD+: 500 mg NAD+ with 2.5 mg BioPerine® per capsule, 30 capsules |
What do human NMN trials show?
Three trials come up again and again, and they are worth knowing by name:
- Yi et al., 2023 (GeroScience). 80 healthy middle-aged adults took a placebo or 300, 600 or 900 mg of NMN daily for 60 days. Blood NAD+ rose in every NMN group, most in the 600 and 900 mg groups. Six-minute walking distance improved compared with placebo, and NMN was well tolerated up to 900 mg. Insulin-resistance scores did not change. Three of the authors were employees of the ingredient companies involved, according to the study's conflict-of-interest statement, which is worth keeping in mind.
- Igarashi et al., 2022 (npj Aging). Healthy older men took 250 mg of NMN a day for 6 or 12 weeks. NMN was well tolerated and raised blood NAD+ and related metabolites. The authors saw small improvements in walking speed and one grip test that they said need confirming in larger studies, and no change in body composition.
- Irie et al., 2020 (Endocrine Journal). Ten healthy men took single 100-, 250-, and 500-mg doses in a non-randomized study. No significant acute clinical symptoms or vital-sign changes were observed over the five hours measured. That tiny observation window cannot establish long-term safety.
Put plainly: several oral NMN trials raise NAD+ measured in blood, and short trials have generally found it well tolerated. But the measured benefit is often a biomarker, not an improvement you can feel. Results on walking and strength are mixed and exploratory; long-term outcomes remain open.
What about taking NAD+ directly?
The logic sounds tidy: why not skip the conversion step? Biology is less tidy. NAD+ outside cells can be broken down into smaller pieces, which may then enter cells and be rebuilt.
Its journey depends on the formulation, tissue, dose, and measurement method. A molecule's job inside a cell does not tell us what happens after you swallow it.
A 2026 randomized trial tested a proprietary, modified oral NAD+ powder in healthy adults aged 45–75.
Sixty were randomized; the primary analysis used 50.
The protocol called for four 500-mg powder doses spread through each day (the powder was 50% NAD+), with an extra night dose on days two and three, taken by swishing and swallowing.
The assay measured total NAD (NAD+ plus NADH), rather than NAD+ alone.
After five days, that whole-blood marker—predominantly a red-blood-cell measure—was 53% higher than placebo, while plasma total NAD did not rise.
That is an interesting short-term biomarker result—not proof of better energy, slower aging, or a benefit from ordinary NAD+ capsules.
The tested powder, route, dosing, and study duration differ from the Infinite Labs product.
So the direct evidence is no longer zero, but it is still much thinner than the NMN trial base. Results from NMN, NR, or a proprietary NAD+ powder cannot simply be pasted onto a different finished formula.
How does NR compare with NMN and NAD+?
Nicotinamide riboside (NR) is the other well-studied precursor. In a crossover trial, healthy middle-aged and older adults took NR for six weeks; it was well tolerated and raised blood NAD+ (Martens et al., 2018).
NR and NMN are closely related: NMN can be converted to NR to enter some cells, and NR becomes NMN again inside them (Covarrubias et al., 2021).
The first direct comparison in people, published in 2026, gave 65 healthy adults NR, NMN or nicotinamide for 14 days: NR and NMN raised blood NAD+ by similar amounts, while nicotinamide did not.
The same study suggests gut bacteria play a part, converting some NR and NMN into nicotinic acid, another NAD+ building block (Christen et al., 2026).
The researchers worked for Nestlé, which sells NR-based products.
So which should you take?
Here is a practical way to think about it:
- If you prioritize a broader published human trial base, NMN is ahead. Most of those trials measured blood NAD+ rather than a proven health outcome.
- If you're drawn to NAD+ itself, keep the formulation distinction front and center. A promising result for one modified powder does not validate every NAD+ capsule.
- Either way, judge a product on its label. Look for the exact amount per capsule, the number of capsules per serving, and no proprietary blend. Compare the cost per 500 mg, not the cost per bottle.
- Keep expectations proportional to the evidence. Do not assume a rise in a lab marker means you will feel different. Follow the product's directions instead of building an elaborate stack around a mechanism.
If you are pregnant or nursing, take prescription medication, or manage a medical condition, talk to your healthcare professional before starting either one.
Can you take NMN and NAD+ together?
We found no randomized human trial testing the two together for an added benefit. Their shared pathway is not, by itself, a reason to stack them. If you are considering both, ask a qualified clinician about your situation and follow each label; more capsules are not a substitute for better evidence.
What the Infinite Labs labels say
Infinite Labs NMN gives you 500 mg in a single veggie capsule, with 60 servings per bottle.
The NAD+ capsule pairs 500 mg of NAD+ with 2.5 mg of BioPerine® black pepper extract in one capsule, with 30 servings.
Both labels also list a plant-cellulose capsule and Nu-FLOW®, a rice-hull flow aid.
Directions for both: one capsule daily with food.
These clearly stated amounts and once-daily directions make either capsule easy to fit into a routine. For more about the brand's ingredient and manufacturing approach, see our approach page.
Frequently asked questions
Is NMN legal in dietary supplements?
In the U.S., the FDA's September 2025 response reversed its earlier conclusion that NMN was excluded from the dietary-supplement definition under the drug-exclusion rule.
That is not blanket approval of every NMN product or claim; ingredient-notification and labeling requirements are separate questions.
Regulatory status can change, so check current FDA guidance before relying on an older article.
How much NMN do studies use?
The trials above used 250 to 900 mg a day, taken once daily. In the largest of them, blood NAD+ rose most at 600 and 900 mg. Follow the directions on your product's label.
When is the best time to take NMN?
No study has shown that a particular time of day works better. The trials gave NMN once a day, and our label says to take one capsule daily with food. Pick a time you can stick to.
Does NMN have side effects?
A 2026 review identified 15 randomized trials; ten contributed to its safety analyses.
Across doses of 250–2,000 mg daily for 14 days to 24 weeks, adverse events and measured liver enzymes did not differ clearly from controls.
That is reassuring for the periods tested, but it cannot establish long-term safety or predict an individual's response.
Is NMN the same as niacin or vitamin B3?
No, but they're relatives. Niacin, nicotinamide, NR and NMN are all forms your body can use to make NAD+, through different routes. Niacin in larger amounts commonly causes skin flushing (NIH Office of Dietary Supplements).
NAD vs NMN: Is NAD+ better because it is the active molecule?
Not necessarily. Being the active molecule doesn't mean it survives digestion intact.
Right now the human evidence is stronger for NMN than for oral NAD+.
Sources
- Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29–43. PubMed 36482258
- Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging. 2022;8(1):5. PubMed 35927255
- Irie J, et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal. 2020. PubMed 31685720
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018. PubMed 29599478
- Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021. PubMed 33353981
- Christen S, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism. 2026;8(1):62–73. PubMed 41540253
- Yang W, et al. Safety and metabolism-related outcomes of oral nicotinamide mononucleotide supplementation in adults: a systematic review and meta-analysis. Nutrients. 2026;18(14):2251. PubMed 42514320
- NIH Office of Dietary Supplements. Niacin: Fact Sheet for Health Professionals. ods.od.nih.gov
- Kornilov SA, et al. Oral LNAD+ rapidly elevates whole-blood intracellular NAD and metabolic flux without elevating plasma NAD: a randomized controlled trial. GeroScience. 2026. PubMed 42530810
- U.S. Food and Drug Administration. Response to NMN citizen petitions, September 29, 2025. FDA response letter
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
About the author
Arjun Sareen is CEO of Infinite Labs and Infinite Labs Digital and contributes to the Infinite Labs Journal. This brand-owned comparison provides educational information, not individual medical advice.




Keep it useful
Join the conversation